0291 (0291) Fair Value & Analysis

Consumer Defensive · Market cap HK$69.0B

0 0291 0291 · HK

PriceHK$21.28

Fair ValueHK$25.18

Upside+18.3%

Quality59/100

Evidence: Medium Range HK$18.88 – HK$31.47

Fair value as of: Jul 1, 2026

From 24 valuation models · updated today

Share price −12.1% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$21.28 – HK$28.33 · fair‑value band HK$18.88 – HK$31.47 · the HK$21.28 price screens below the HK$25.18 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0291 (0291) currently trades at HK$21.28, while our model-based Fair Value estimate is HK$25.18 — implying the stock looks roughly 18.3% undervalued today. We read business quality at 59/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 0291 generated revenue of HK$38.0B at a net margin of 8.9%. Revenue declined 5.7% year over year. It earns a return on equity of 8.9%. The balance sheet holds a net cash position of HK$3.5B. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$38.0B

Revenue growth (YoY) -5.7%

Net margin 8.9%

Return on equity 8.9%

Free cash flow HK$5.3B FY2025

P/E ratio 17.7

More key figures

Operating margin -3.1%

EPS (TTM) HK$1.78

Dividend yield 4.7%

EPS growth (YoY) +23.0%

Net cash HK$3.5B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0291 reported revenue of HK$38.0B in FY2025 versus HK$33.4B in FY2021, a compound +3.3%/yr. Reported net income was HK$3.4B in FY2025, compounding −7.4%/yr from FY2021.

Revenue +3.3%/yr

FY21 HK$33.4B

FY22 HK$35.3B

FY23 HK$38.9B

FY24 HK$38.6B

FY25 HK$38.0B

Net income −7.4%/yr

FY21 HK$4.6B

FY22 HK$4.3B

FY23 HK$5.2B

FY24 HK$4.7B

FY25 HK$3.4B

Is 0291 fairly valued? → Check now

Similar stocks

6 more Beverages - Brewers stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
Ambev S.A ABEV	14,120 ARS	5,676 ARS	-60%
Anheuser-Busch InBev SA BUDFF	$81.40	$58.28	-28%
1NBA 1NBA	€71.18	€70.95	-0%
Fomento Económico Mexicano, S.A. FEMSAUBD	213.28 MXN	429.71 MXN	+101%
Heineken N.V HINKF	$81.75	$69.53	-15%
Constellation Brands, Inc STZ	$143.38	$177.43	+24%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0291 (0291) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$25.18 versus a price of HK$21.28 — about +18% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0291?

Our model-based fair value for 0291 is HK$25.18 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$21.28.

What is the quality score of 0291?

0291 has a Quality Score of 59/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0291 (0291)?

0291 reported trailing-twelve-month revenue of about HK$38.0B (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0291?

The net profit margin of 0291 is about 8.9%, meaning it keeps roughly 8.9% of revenue as net income. Based on the latest reported figures.

Does 0291 pay a dividend?

0291 currently shows a dividend yield of about 4.65% relative to its recent price (as of Jul 1, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.